VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd

Bullboard Posts

Post by Whiskeytimeon Mar 03, 2017 12:55pm

107 Views

Post# 25927839

Level 2

LEVEL 2 QUOTE

Shares	Bid Price	Ask Price	Shares
42,000	0.530	0.540	5,000
86,500	0.520	0.550	55,000
146,500	0.510	0.560	34,000
69,500	0.500	0.570	45,000
3,000	0.495	0.580	30,500
15,000	0.490	0.590	49,000
30,000	0.485	0.600	114,000
82,000	0.480	0.610	25,000
30,000	0.470	0.620	72,500
112,000	0.460	0.630	46,000